- Measles alert in your area? Here’s what to do next
-
2026.02.26
As measles cases surge across the U.S., reaching the highest numbers in decades, public health officials are increasingly issuing exposure alerts to help communities respond quickly to prevent further spread.
Why swift action is needed: Measles is highly contagious, with a single person infecting up to 18 other unprotected individuals. And, the virus doesn’t just spread through close contact—it “can remain infectious while suspended in the air, or survive on surfaces, for up to two hours,” says William Moss. That means that someone can be exposed even after an infected person has left the room. In communities where vaccination coverage is below the recommended threshold of 95%, even one case can quickly snowball into a broader outbreak.
What exactly is a measles exposure alert? When someone with a confirmed case of measles has been in a public place while contagious, health departments attempt to contact everyone who may have been exposed. If they are unable to, they issue an alert—often via news releases and social media—with the exact location, date, and timeframe when the infectious individual was present (e.g., “Tuesday, February 10, between 2 p.m. and 6 p.m., at the North Train Station”), so that anyone who was also in that location around that time can act quickly to protect themselves.
These alerts are “precautionary, and not a reason to panic,” says Darcy Phelan-Emrick. Their purpose is to give people clear, time-sensitive information so they can make informed decisions about vaccination, monitoring symptoms, or contacting a provider.
From the Johns Hopkins Bloomberg School of Public Health Wednesday, February 25, 2026
- The latest pneumococcal vaccine recommendation for those 50 years of age and older 11/04/25
-
2025.11.04
The Centers for Disease Control and Prevention recommends that people 50 years of age receive one dose of Prevnar 20® or Capvax® once in their lifetime, even if they have received other pneumococcal vaccines in the past.
- Electronic payments only
-
2025.05.07
We promotes cashless payment at the counter. Both insured and uninsured treatments are accepted.
Credit cards/Pay are accepted. - Antigen test for dengue fever available.
-
2025.05.07
In fact, there are currently more outbreaks of dengue fever than measles in Japan.
The three main initial symptoms of dengue fever are ‘sudden high fever, pain behind the eyes and severe joint pain’, and the incubation period is mainly 4-7 days. It is the first infectious disease to be considered, especially if a sudden fever occurs after travelling to South-East Asia. The antigen test is based on a blood sample. Total cost ¥ 10,620 (incl. tax) - Tick-borne encephalitis vaccine is now available.
-
2025.03.04
This vaccine is against Tick-Borne Encephalitis(TBE) caused by a virus carried by ticks that live from Eastern Europe to Russia and from Far Eastern Russia to north-eastern China and partly to Hokkaido. It is recommended especially for long-term stays in Eastern Europe.
- Major respiratory viral diseases (COVID, influenza, RS) monitoring status
-
2024.10.19
Seasonal respiratory viral diseases, whether influenza or RS viruses, show almost the same epidemic timing and dynamics worldwide.
The C.D.C utilises data from sewage samples and emergency department visits to graphically display the effective reproduction numbers and publish the real-time epidemic status, i.e. ‘now’ and ‘which way it is going’, at a glance. - RS virus vaccine
-
2024.01.15
RS virus is a respiratory infection virus that, like influenza, causes pneumonia; RS virus infections are generally mild in adults, but can cause hospitalization for pneumonia, especially if there is an underlying medical condition. It is as contagious as influenza and can have a similar or slightly higher mortality rate.
The efficacy of the adult RS virus vaccine (Arexvy ®︎) against the development of lower respiratory tract disease caused by RS virus in adults aged 60 years and older was 82.5% and 94.6%, especially in adults with chronic obstructive pulmonary disease, asthma, chronic respiratory/lung disease, diabetes, chronic heart failure, advanced liver or renal disease. Major adverse reactions were reported as swelling or pain at the vaccination site in 60% and fatigue/muscle pain in 30%.
At present, the vaccine is supposed to be given once a year in fall and winter. There are no restrictions on the interval between vaccinations with other vaccines (except the corona vaccine), and simultaneous vaccination is possible.
- We do not require patients to wear masks when you come to our clinic, except for those with coughing.
-
2023.11.08
As a rule, staff members at our clinic do not wear masks. As an exception, only a doctor wear masks. Regardless of the prevalence of coronavirus, physicians who are in close proximity to patients are at extremely high risk of direct droplet exposure. Doctor is at risk of exposure not only to ordinary cold viruses such as influenza, but also to severe infectious agents such as Mycobacterium tuberculosis. Tuberculosis, for example, is estimated to infect as many as one-third of the world’s population if latent TB infection is included.
- Currently, there is a severe shortage of antipyretics, cough medicines, antibiotics, anti-diarrhea medicines, and many other medicines on the market, so prescriptions may not meet your requests.
-
2023.11.07